GeoVax Labs, Inc. (GOVX) |
|
2.26 0.01 (0.44%)
|
08-18 07:19 |
|
Open: |
2.53 |
Pre. Close: |
2.25 |
|
High:
|
2.37 |
Low:
|
2.15 |
|
Volume:
|
5,056,696 |
Market Cap:
|
56(M) |
|
|
|
|
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. The company has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; Centers for Disease Control and Prevention; U.S. Department of Defense; Emory University; University of Pittsburgh; and the Burnet Institute. GeoVax Labs, Inc. was incorporated in 1988 and is based in Smyrna, Georgia. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
2.53 - 2.55 |
2.55 - 2.56 |
|
Low:
|
2.12 - 2.14 |
2.14 - 2.15 |
|
Close:
|
2.24 - 2.26 |
2.26 - 2.28 |
|
Technical analysis |
as of: 2022-08-17 4:23:47 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 3.38 One year: 5.02 |
| Support: |
Support1: 0.62 Support2: 0.51 |
| Resistance: |
Resistance1: 2.89 Resistance2: 4.3 |
| Pivot: |
2.79  |
| Moving Average: |
MA(5): 2.45  MA(20): 2.41
MA(100): 1.37 MA(250): 2.57 |
| MACD: |
MACD(12,26): 0.3 Signal(9): 0.4 |
| Stochastic oscillator: |
%K(14,3): 25.6 %D(3): 35.6 |
| RSI: |
RSI(14): 51.3 |
| 52-week: |
High: 6.9 Low: 0.55 |
| Average Vol(K): |
3-Month: 23,238 (K) 10-Days: 20,535 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ GOVX ] has closed above bottom band by 22.2%. Bollinger Bands are 51.3% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 16 days. This is a sign that the current trend might continue. |
|
|
Headline News |
Wed, 17 Aug 2022
Geovax Labs Inc (GOVX) Down 4.44% in Premarket Trading - InvestorsObserver
Tue, 16 Aug 2022
GovX Supports San Diego 9/11 Memorial Stair Climb: Honors Fallen and Current Firefighters - PR Web
Fri, 12 Aug 2022
Need to Know Monkeypox News for Investors (BVRNY, TOMDF, GOVX, APDN, NNVC) - Marketscreener.com
Fri, 05 Aug 2022
GovX Raises Over $11,000 for FOLDS OF HONOR Veteran Nonprofit for Month of July - PR Web
Fri, 05 Aug 2022
Premarket Mover: Geovax Labs Inc (GOVX) Down 2.80% - InvestorsObserver
Wed, 03 Aug 2022
Healthcare Stocks Moving Wednesday: QNRX, HSDT, HSCS, PSTX, HZNP, GOVX, SNTI, BBIO - InvestorsObserver
|
Financial Analysis |
| Price to Book Value: |
Neutral |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. |
0 (M) |
| Shares Float |
13 (M) |
|
% Held by Insiders
|
9.24e+006 (%) |
|
% Held by Institutions
|
2.2 (%) |
|
Shares Short
|
340 (K) |
|
Shares Short P.Month
|
0 (K) |
Stock Financials |
|
EPS
|
-1.956e+007 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
0 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
-5 |
|
Return on Assets (ttm)
|
498.9 |
|
Return on Equity (ttm)
|
-64.6 |
|
Qtrly Rev. Growth
|
356610 |
|
Gross Profit (p.s.)
|
-8.22 |
|
Sales Per Share
|
-38.08 |
|
EBITDA (p.s.)
|
-4.75549e+006 |
|
Qtrly Earnings Growth
|
-3 |
|
Operating Cash Flow
|
0 (M) |
|
Levered Free Cash Flow
|
-14 (M) |
Stock Valuations |
|
PE Ratio
|
-0.01 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0 |
|
Price to Sales
|
-0.06 |
|
Price to Cash Flow
|
6 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
100340 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
2020-09-24 |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
